| Issue Date |
Title |
Author(s) |
| Jul-2021 |
D-0316 in patients with advanced T790M-positive EGFR-mutant non-small cell lung cancer who progressed on prior EGFR-TKI therapy: results from a phase II study (NCT03861156). |
Lu, Shun;Zhang, Yiping;Zhang, Guojun;Zhou, Jianying;Cang, Shundong;Cheng, Ying;Wu, Gang;Cao, Peiguo;Lv, Dongqing;Jin, Xiangming;Jian, Hong;Chen, Chengshui;Jiang, Guanming;Tian, Panwen;Wang, Kai;Zhao, Hui;Chen, Gongyan;Chen, Qun;Ding, Cuimin;Yang, Junquan;Guo, Renhua;Sun, Guoping;Wang, Bin;Jiang, Liyan;Zhuang, Wu;Liu, Zhe;Fang, Jian;Liu, Yunpeng;Zhang, Jian;Chen, Jun;Pan, Yueyin;Yu, Qitao;Zhao, Min;Cui, Jiuwei;Li, Dianming;Yi, Tienan;Yu, Zhuang;Yang, Yan;Zhang, Yan;Zhi, Xiuyi;Huang, Yunchao;Wu, Rong;Chen, Liangan;Zang, Aimin;Cao, Lejie;Li, Qingshan;Li, Xiaoling;Song, Yong;Wang, Donglin;Zhang, Shucai |
| 4-Oct-2022 |
The effectiveness and safety of the rapid titration strategy of background controlled-release oxycodone hydrochloride for patients with moderate-to-severe cancer pain: A retrospective cohort study |
Feng, Weineng;Wang, Yufeng;Ran, Fengming;Mao, Yong;Zhang, Helong;Wang, Qifeng;Lin, Wen;Wang, Zhidong;Hu, Jianli;Liao, Wangjun;Zhang, Tao;Chu, Qian;Xiong, Weijie;Yi, Tienan;Yi, Jiqun;Ma, Shoucheng;Sun, Yi;Meng, Lingzhan;Liu, Chunling;Zhou, Silang;Zheng, Dengyun;Wang, Shubin;Lin, Haifeng;Fang, Wenzheng;Li, Jun;Wu, Minhui |
| 10-Sep-2022 |
Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study |
Shen, Lin;Kato, Ken;Kim, Sung-Bae;Ajani, Jaffer A.;Zhao, Kuaile;He, Zhiyong;Yu, Xinmin;Shu, Yongqian;Luo, Qi;Wang, Jufeng;Chen, Zhendong;Niu, Zuoxing;Zhang, Longzhen;Yi, Tienan;Sun, Jong-Mu;Chen, Jianhua;Yu, Guohua;Lin, Chen-Yuan;Hara, Hiroki;Bi, Qing;Satoh, Taroh;Pazo-Cid, Roberto;Arkenau, Hendrick-Tobias;Borg, Christophe;Lordick, Florian;Li, Liyun;Ding, Ningning;Tao, Aiyang;Shi, Jingwen;Van Cutsem, Eric |
